Antibody (6)Panel (1)
En ligne (7)
Rabbit (7)
- (7)
Unconjugated (2)- (1)HRP Labeled (2)Biotin-labeled (2)
| Numéro de produit | Espèces | Système d'expression | Description du produit | Structure protéique | Pureté | Caractéristiques | Pré-commande/Commande |
|---|---|---|---|---|---|---|---|
HEK293 | Anti-PBD Antibody Screening Panel | ||||||
HEK293 | Monoclonal Anti-Payload PBD Antibody, Rabbit IgG (1M1F9) | ||||||
HEK293 | Monoclonal Anti-Payload PBD Antibody, Rabbit IgG (M1D08) | ||||||
HEK293 | Biotinylated Monoclonal Anti-PBD Antibody, Rabbit IgG (1M1F9) | ||||||
HEK293 | Biotinylated Monoclonal Anti-PBD Antibody, Rabbit IgG (M1D08) | ||||||
HEK293 | HRP conjugated Monoclonal Anti-PBD Antibody, Rabbit IgG (1M1F9) | ||||||
HEK293 | HRP conjugated Monoclonal Anti-PBD Antibody, Rabbit IgG (M1D08) |
| Nom anglais | Code de recherche | Phase de R&D | Entreprise | Indication | Essai clinique |
|---|---|---|---|---|---|
| Polyclonal antibody stimulator (Cancer Advances) | G-17DT | Phase 2 Clinical | Aphton Corp | Diabetes Mellitus, Type 1; Stomach Neoplasms; Esophageal Neoplasms; Pancreatic Neoplasms; Colorectal Neoplasms; Jaundice | Details |
